Literature DB >> 28971816

Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma.

Tetsuya Tanimoto1, Kumi Oshima2, Kenji Tsuda3, Jinichi Mori2, Hiroaki Shimmura4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28971816     DOI： 10.1016/S1470-2045(17)30706-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study.

Authors:  Hongnan Mo; Peng Liu; Yan Qin; Xiaohui He; Xiaohong Han; Jiarui Yao; Weicai Su; Shuxiang Zhang; Le Tang; Fengyi Zhao; Lin Gui; Sheng Yang; Jianliang Yang; Shengyu Zhou; Zhishang Zhang; Yuankai Shi
Journal:  Chronic Dis Transl Med       Date:  2021-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.